<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="935">
  <stage>Registered</stage>
  <submitdate>9/12/2005</submitdate>
  <approvaldate>12/12/2005</approvaldate>
  <actrnumber>ACTRN12605000786695</actrnumber>
  <trial_identification>
    <studytitle>Comparison of a single dose of intravenous paracetamol with rectal paracetamol and placebo in the treatment of mild to moderate postoperative pain</studytitle>
    <scientifictitle>Comparison of a single dose of intravenous paracetamol with rectal paracetamol and placebo in the treatment of mild to moderate postoperative pain</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Postoperative pain</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Single dose of either intravenous or rectal paracetamol prior to induction of anaesthesia</interventions>
    <comparator>Placebo.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain relief by VAS (Visual Analogue Score) in the postoperative period</outcome>
      <timepoint>At awakening and at discharge from recovery area</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>1. Total dose of rescue analgesia (morphine) required in recovery period.</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>2. Side effects of iv paracetamol measured by SAQ (Symptom Assessment Questionnaire).</outcome>
      <timepoint>Pre and postoperatively. </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>3. Paracetamol plasma levels</outcome>
      <timepoint>Measured at 30, 60 and 120 min after administration.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Female patients undergoing minor laparoscopic gynaecological surgeryASA I and II.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Allergy to paracetamol and/or morphineHepatic or renal dysfunction.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Numbered containers for iv paracetamol/saline and paracetamol/glycerine suppositories</concealment>
    <sequence>When patients fulfill inclusion criteria they will be randomised to one of 3 groups according to a computer generated randomisation table</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>16/01/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Bristol-Myers Squibb</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Bristol-Myers Squibb</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane &amp; women Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dominique Hopkins</name>
      <address>Department of Anaesthesia
Royal Brisbane and Women Hospital
Level 4
Ned Hanlon Building
Herston QLD 4026</address>
      <phone>+61 7 36367135</phone>
      <fax />
      <email>Dominique_Hopkins@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dominique Hopkins</name>
      <address>Department of Anaesthesia
Royal Brisbane and Women Hospital
Level 4
Ned Hanlon Building
Herston QLD 4026</address>
      <phone>+61 7 36367135</phone>
      <fax />
      <email>Dominique_Hopkins@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>